Home/Filings/4/0001127602-25-003500
4//SEC Filing

Grygiel Nancy A. 4

Accession 0001127602-25-003500

CIK 0000318154other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 8:54 PM ET

Size

5.7 KB

Accession

0001127602-25-003500

Insider Transaction Report

Form 4
Period: 2025-02-05
Transactions
  • Sale

    Common Stock

    2025-02-05$304.47/sh1,589$483,8087,210 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    102.219
Footnotes (2)
  • [F1]These shares include 114 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F2]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001816414

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:54 PM ET
Size
5.7 KB